Abbott insider plans sale of up to 398,832 shares

ABBOTT LABORATORIES (ABT) received a Rule 144 notice from Robert B. Ford covering a proposed sale of its common stock.

Rhea-AI Filing Summary

ABBOTT LABORATORIES (ABT) received a Rule 144 notice from Robert B. Ford covering a proposed sale of its common stock. The notice indicates an intention to sell up to 398,832 shares of Abbott common stock through UBS Financial Services, Inc., with sales beginning on or after August 25, 2026. The shares are to be acquired via exercise of stock options for cash before being sold.

Key Figures

Shares to be sold: 398,832 shares of common stock Proposed sale start date: 08/25/2026 Method of acquisition: Exercise of stock options +1 more

4 metrics

Shares to be sold 398,832 shares of common stock Maximum number of ABBOTT LABORATORIES shares covered by the Rule 144 notice

Proposed sale start date 08/25/2026 Date on or after which the shares may be sold under Rule 144

Method of acquisition Exercise of stock options Source of the shares that are proposed to be sold

Consideration for option exercise Cash Form of payment for exercising stock options to obtain the shares

Key Terms

Rule 144, Exercise of Stock Options, Power of Attorney

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Exercise of Stock Options financial

"Common | 08/25/2026 | Exercise of Stock Options | Issuer"

Power of Attorney regulatory

"Signature | /s/ Aaron N. Rice, by Power of Attorney for Robert B. Ford"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for ABBOTT LABORATORIES (ABT) disclose?

It discloses that Robert B. Ford has filed a Rule 144 notice for a proposed sale of up to 398,832 shares of Abbott Laboratories common stock, to be sold through UBS Financial Services, Inc. beginning on or after August 25, 2026.

How many ABBOTT LABORATORIES (ABT) shares are covered by this Rule 144 notice?

The notice covers up to 398,832 shares of Abbott Laboratories common stock. These shares are tied to an exercise of stock options for cash prior to their potential sale under Rule 144.

When can the ABT shares under this Form 144 start being sold?

The shares covered by this Form 144 may be sold on or after August 25, 2026. This date appears as the proposed sale date and the date of the stock option exercise that will provide the shares for sale.

How will Robert B. Ford obtain the ABBOTT LABORATORIES (ABT) shares to be sold?

The filing states the shares will come from an exercise of stock options with consideration listed as cash. After exercising the options for cash, the resulting common shares may be sold under Rule 144.

Which broker is named for the planned ABBOTT LABORATORIES (ABT) share sales?

The planned sales are listed through UBS Financial Services, Inc., located at 1000 Harbor Blvd., 3rd Floor, Weehawken, NJ 07086. The securities referenced are Abbott Laboratories common stock, listed on the NYSE.

Who signed the Form 144 related to ABBOTT LABORATORIES (ABT)?

The Form 144 is signed as “/s/ Aaron N. Rice, by Power of Attorney for Robert B. Ford” with a date of August 25, 2026, indicating it was executed under a power of attorney on behalf of Robert B. Ford.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/25/2026 - 06:05 PM EDT Accepted by SEC EDGAR 08/25/2026 - 06:05 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001612571
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ABBOTT LABORATORIES
SEC File Number	001-02189
Address of Issuer	100 ABBOTT PARK ROAD ABBOTT PARK ILLINOIS 60064
Phone	(224) 667-6100
Name of Person for Whose Account the Securities are To Be Sold	Robert B. Ford
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 1000 Harbor Blvd. 3rd Floor Weehawken NJ 07086	398832	46204386	1730383296	08/25/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/25/2026	Exercise of Stock Options	Issuer			398832	08/25/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/25/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Aaron N. Rice, by Power of Attorney for Robert B. Ford
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)